Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, HomologousGraft vs Host DiseaseTransplantation, AutologousTransplantation ConditioningHematologic NeoplasmsHematopoietic Stem Cell MobilizationBone Marrow TransplantationGranulocyte Colony-Stimulating FactorGraft SurvivalTransplantation ChimeraTissue DonorsAntigens, CD34BusulfanLeukapheresisImmunosuppressive AgentsTreatment OutcomeVidarabineRecurrenceGraft vs Leukemia EffectBlood Component RemovalStem CellsHematopoietic Stem CellsStem Cell TransplantationHistocompatibilityRetrospective StudiesHistocompatibility TestingSurvival AnalysisMyeloablative AgonistsLeukemiaMelphalanWhole-Body IrradiationCombined Modality TherapyChronic DiseaseCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationDisease-Free SurvivalT-LymphocytesLymphoma, Non-HodgkinBlood CellsHLA AntigensCytomegalovirus InfectionsPrecursor Cell Lymphoblastic Leukemia-LymphomaRemission InductionBlood Cell CountEtoposideTime FactorsHematopoiesisAntineoplastic Agents, AlkylatingTransplantation, IsogeneicSalvage TherapyTransplantation ImmunologyOpportunistic InfectionsThiotepaCyclosporineSurvival RateBlood DonorsInfectionAnemia, AplasticBone Marrow PurgingLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantationImmunocompromised HostHematologic DiseasesHodgkin DiseaseLymphocyte DepletionLeukocyte TransfusionCytarabineIfosfamideFlow CytometryRecombinant ProteinsNeoplasmsPlatelet CountCell SeparationEmbryonic Stem CellsImmunophenotypingImmunosuppressionLymphomaLeukocytes, MononuclearAcute DiseaseFatal OutcomeBone MarrowMyelodysplastic SyndromesVincristineFollow-Up StudiesBone Marrow CellsCytomegalovirusLymphocyte TransfusionAdult Stem CellsFeasibility StudiesGraft vs Tumor EffectPlatelet TransfusionPOEMS SyndromeProspective StudiesLeukocyte CountCells, Cultured